Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The role of plasmapheresis in the treatment of amiodarone-induced thyrotoxicosis (CROSBI ID 142249)

Prilog u časopisu | prikaz, osvrt, kritika

Korljan Babić, Betty ; Ljutić, Dragan ; Brnić, Darko ; Dodig, Josipa The role of plasmapheresis in the treatment of amiodarone-induced thyrotoxicosis // Dialysis & transplantation, 36 (2007), 4; 227-229

Podaci o odgovornosti

Korljan Babić, Betty ; Ljutić, Dragan ; Brnić, Darko ; Dodig, Josipa

engleski

The role of plasmapheresis in the treatment of amiodarone-induced thyrotoxicosis

Thyrotoxicosis, a life-threatening condition characterized by an excess of thyroid hormones with typical clinical manifestations and high mortality, is a well-known amiodarone side effect. Amiodarone is a highly effective antiarrhythmic drug that contains 37% iodine by weight and has a structural resemblance to thyroid hormones. The average prevalence of amiodarone-induced thyrotoxicosis is about 5%. Because of long terminal half-life amiodarone-induced thyroid dysfunction is very difficult to treat by discontinuation of amiodarone and antithyroid drugs.4, 9-11 Plasmapheresis is already known as a very effective therapeutic method for patients with thyrotoxicosis.12 Here we report on a patient with thyrotoxicosis who was successfully treated with plasmapheresis.

plasmapheresis; amiodaron; thyrotoxicosis; treatment

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

36 (4)

2007.

227-229

objavljeno

0090-2934

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost